The c-Yes proto-oncogene (pp62 c-Yes ) encodes a nonreceptor-type protein tyrosine kinase (NRPTK) of the Src family. c-Yes activities and protein levels are elevated in human melanoma and melanocyte cell lines. Because the neurotrophins (NT) are important in the progression of melanoma to the brain-metastatic phenotype, we determined whether NT stimulate c-Yes activity in human MeWo melanoma cells and two variant sublines with opposite metastatic capabilities, 3 S 5 and 70W. The highly brain-metastatic 70W subline had an intrinsically higher c-Yes activity than parental MeWo or poorly metastatic 3 S 5 cells. c-Yes kinase was further induced by the prototypic human NT, nerve growth factor (NGF) in a dose and time-dependent manner. In contrast, c-Src activity (pp60 c-Src ) was similar in all these cells and unaected by NGF exposure. Additionally, human NGF and neurotrophin-3 stimulated c-Yes in brain-metastatic 70W cells. The magnitude of cYes activation correlated with the degree of invasion of 70 W cells following incubation of these neurotrophins. To further examine NT stimulation of c-Yes in melanoma cells, three additional cell lines were examined. Metastatic TXM-13 and TXM-18 increased c-Yes activity in response to NGF. In contrast, no increase was observed in low-metastatic TXM-40 cells. Together, these data suggest that altered c-Yes expression may play a role in the malignant progression of the human melanocyte towards the brain-metastatic phenotype and that NT enhance the activity of c-Yes in signaling penetration into the matrix of NT-rich stromal microenvironments such as the brain.
Introduction
Malignant melanoma metastasizes to the brain more often than any other cancer that is capable of colonizing the CNS: patients with disseminated malignant melanoma frequently develop metastatic lesions in the brain and spinal cord that can result in severe and debilitating conditions (Wright and Delaney, 1989; Steck and Nicolson, 1993) . Melanomas undergo progressive changes during their malignant progression. Of the phenotypic changes that occur during their development into tumors capable of forming brain metastases, dierences in the production of various autocrine growth factors and in the expression of receptors for paracrine growth factors are important (Herlyn et al., 1985; Albino et al., 1991; Nicolson, 1993a,b) . For example, brain-metastatic murine and human melanoma cells respond to select members of a family of neurotrophic factors called the neurotrophins (NT). NT including nerve growth factor (NGF), brain-derived neurotrophic factor (BDNF), neurotrophin-3 (NT-3), and neurotrophin-4/5 (NT-4/ 5) (Chao, 1992) can bind not only to the low-anity p75 neurotrophin receptor (p75 NTR ) (Bothwell, 1990; Chao, 1992; Barbacid, 1993) but also to the highanity NTR represented by the TRK family of tyrosine kinase receptors (Bothwell, 1990; Lamballe et al., 1991; Chao, 1992; Barbacid, 1993) . Malignant melanoma cells express p75 NTR in direct relation to their malignancy and ability to metastasize to the brain (Marchetti et al., , 1995 Herrmann et al., 1993) within regions that synthesize and respond to NT (Marchetti et al., 1995) . We have found that NT aect invasive processes in brain-metastatic melanoma and production of extracellular matrix (ECM-degrading enzymes . These in vitro observations have been con®rmed in clinical specimens from patients with metastatic melanomas at dierent stages of tumor progression. Such studies have revealed an inverse relationship between an overexpression of NTR in brain-metastatic cells and NT in those brain regions facing the invasive from (Marchetti et al., 1995) . Like other receptor tyrosine kinase receptors, NTR are involved in a sequence of events that include ligand binding leading to receptor dimer formation, transactivation resulting in tyrosine phosphorylation, and eventually activation of serine/threonine phosphorylation cascades. Active signaling complexes can be formed by interactions between receptor phosphotyrosines and proteins containing Src homology-2 (SH-2) domains. Signal transduction by NGF in pheochromocytoma cells (PC-12) seems to require a concerted action of Src and Ras proteins (Kremer et al., 1991) .
Non-receptor protein tyrosine kinases (NRPTK) of the c-Src family have been implicated in several signal transduction processes including cellular growth, dierentiation, malignant transformation and progression (Golden and Brugge, 1988; Bishop, 1991; Brickell, 1992; Sudol, 1992; Hunter and Cooper, 1985; Hunter, 1997) . In human tumors, no mutations of these genes have been identi®ed. However, increased speci®c tyrosine kinase activity of pp60 c-Src frequently occurs in several human tumors including tumors of the colon (Cartwright et al., 1993) , bladder (Fanning et al., 1992) , breast (Ottenho-Kal et al., 1992) , and skin (Barnekow et al., 1987) . Recently, increases in pp60 kinase activity have been associated with colon metastases Termuhlen et al., 1993) , suggesting that this class of kinase may be important in malignant progression. c-Yes kinase is expressed at elevated levels in epithelial cells and in speci®c areas of the brain (Sudol et al., 1989) . Activation of the c-Yes kinase has also been demonstrated to occur in colon Termuhlen et al., 1993) and, of relevance, in malignant melanoma (Loganzo et al., 1993) . The role of activation of these kinases in tumor progression remains unknown.
In this study we examined the relationship between NT that increase the metastatic potential of melanoma cell lines and pp60 c-Src and pp62 c-Yes activity. We therefore examined (a) the intrinsic levels of expression of pp60 c-Src and pp62 c-Yes in human melanoma cell lines, (b) the ability of NT to stimulate pp60 c-Src and pp62
c-Yes activity and (c) if this stimulation correlated with the brain-metastatic potential of the cells examined. For these purposes, we used three related human melanoma cell lines, namely the parental MeWo and two wheat germ agglutinin (WGA)-selected MeWo variants, of opposite metastatic capabilities, the poorly metastatic 3 S 5 and the highly brain-metastatic 70W sublines (Ishikawa et al., 1988a,b) . The 70W variant displays a highly aggressive pattern in in vivo experimental metastases: a unique model, it is the ®rst example of human melanoma capable of brain-metastasis formation when injected intravenously into nude mice (Ishikawa et al., 1988a,b) . As such, colonization of the target organ site by 70W cells is similar to the clinical presentation of human melanoma metastasis in advanced disease stages. Additionally, we examined three other human melanoma cell lines, TXM-13, TXM-18, and TXM-40 of varying brain-metastatic potential.
In the present report, we show that the activity and level of c-Yes, but not c-Src, are upregulated in human brain-metastatic 70W cells, that such activity correlates with the metastatic potential of human melanoma cells, that stimulation of c-Yes by select NT correlates with their capacity to act as brain-invasive factors and with increased expression of p75 NTR and TrkC present in these cells (Marchetti et al., , 1995 Herrmann et al., 1993) . These results suggest a speci®c role of NRPTKs activation in melanomas, and the potential involvement of NRPTKs in the development of brain metastases. They also suggest that pp62 c-Yes may be a downstream target of the NT response pathways important in the increased brain-metastatic capabilities of cells.
Results
Relation between c-Yes and c-Src NRPTK levels and NTR content in human melanoma cells
The levels of c-Yes (pp62 c-Yes ) and c-Src (pp60 c-Src ) proteins and kinase activities were compared in lysates of human melanoma cells of the MeWo series by Western blot analysis and ICKA. These results were related to protein NTR content in these cells by performing NTR (p75 NTR and TrkC) immunoprecipitation studies, as previously reported (Herrmann et al., 1993) . Figure 1 shows the results of a representative Western blot analysis using c-Src and c-Yes antibodies designed to determine c-Src and c-Yes levels in human parental MeWo and its two variants, 3 S 5 and 70W, possessing dierent and contrasting metastatic capabilities (Ishikawa et al., 1988a,b) . These data were compared with overexpression and dierential content of NTR (p75 NTR and TrkC) in these cells (Figure 1a ). Levels of c-Yes protein were elevated approximately twofold in brain-metastatic 70W versus poorly metastatic 3 S 5 cells (Figure 1 ). Parallel analysis with antibodies to c-Src also indicated that these melanoma cells had nearly identical levels of this PTK and lower with respect to c-Yes levels (Figure 1 ). Coomassie bluestained gels con®rmed equal loading of protein.
Correlation of increased c-Yes activity with c-Yes expression
Following the determination of c-Yes and c-Src levels in human melanoma by Western blotting, we wanted to investigate whether such protein expression was paralleled by similar increases in c-Yes kinase activity and compare these investigations with parallel ones /pp62 c-Yes kinase levels in human melanoma cells of dierent metastatic capability. Parental MeWo cells, and two variants 3 S 5 (poorly metastatic) and 70W (brain-metastatic) were grown at 378C to subcon¯uency (70 ± 80%) as described in Materials and methods. Cells were then harvested and analysed for NTR (p75 NTR , TrkC) receptor content through immunoprecipitation as previously reported (Herrmann et al., 1993) . pp60
c-Yes in human melanoma cells were analysed by Western blotting. MeWo, 3 S 5, 70W were harvested and equal amounts of protein from each cell line (as determined by Coomassie Blue gel staining) were loaded and electrophoresed in SDS-polyacrylamide gels. Subsequently, they were transferred to nitrocellulose as described (see Materials and methods). Molecular size markers (in kilodaltons) were run in parallel and the positions of speci®c molecular weights are indicated These results con®rm that the intrinsic speci®c activity of pp62 c-Yes as well as its expression levels are increased in more metastatic melanoma cells, as ®rst demonstrated by Loganzo et al., 1993. Activity and levels of pp62 c-Yes but not pp60 c-Src are NGF dose-and time-dependent To investigate the relationship between NTs and Yes/ Src kinases as possible downstream targets of NT signaling through cell-surface NTR in melanoma, changes in activity following NT stimulation were determined. Dose-and time-dependent ICKAs were performed on MeWo, 3 S 5, and 70W cells coincubated with various amounts of puri®ed and biologically active prototypic NT, human NGF. A representative ICKA in presence of dierent amounts of NGF is shown in Figure 3 . The optimal concentration of NGF needed to induce maximal NGF's activity in the regulation of c-Yes activity was at 50 ng/ml or approximately 2 nM. ICKAs of these samples showed a similar 2 ± 3-fold increase in c-Yes autophosphorylation in brain-metastatic 70W melanoma when compared with parental MeWo or poorly metastatic 3 S 5 melanoma cells. The NGF value correlated well with the results of our previous investigations that monitored the NGF regulation of growth and invasion of various melanoma cells of dierent source and metastatic capabilities . In parallel assays, NGF (2 ± 200 nM) did not stimulate the tyrosine kinase activity of pp60 c-Src and pp62 c-Yes kinase activities in MeWo, 3 S 5, and 70W cells. For immune complex kinase assays (ICKA), 250 mg of total protein from cell lysates were incubated with speci®c monoclonal antibodies to c-Yes and c-Src. ICKA were subsequently performed as described in Materials and methods. Samples were fractionated on 8% SDS-polyacrylamide gels which were dried and exposed to Kodak X-AR ®lm. Autophosphorylation of pp60 c-Src and pp62 c-Yes are displayed in the autoradiogram, representative of independent experiments with similar reproducible results , and ICKA were performed and electrophoresed as described in Materials and methods. Representative autoradiograms of independent experiments are shown 
c-Yes activity in human brain-metastatic melanoma
To determine if other neurotrophins that increase the metastatic potential also stimulated pp62 c-Yes kinase activity, we examined another member of NT family, namely, NT-3. Incubation of human melanoma cells of the MeWo series with the human NTs NGF and NT-3 resulted in a 3 ± 5-fold increase in c-Yes activity in the brain-metastatic 70W cells, but not in parental MeWo and poorly-metastatic 3 S 5 cells (Figure 6 ). The c-Yes activation was found to be speci®c for NGF and NT-3, correlating with aberrant levels of p75 NTR and TrkC found in brain-metastatic cells, as speci®c receptors for NGF and NT-3 respectively.
NGF stimulation of pp62
c-Yes activity in human melanoma TXM cell lines
We next analysed the activation of pp62 c-Yes and pp60 c-Src activities by the prototypic NT, NGF, in human melanoma cell lines of the TXM series, to further determine if NT stimulate c-Yes activity preferentially in cells that metastasize to the brain. The TXM designated cell lines (TXM-13, TXM-18, and TXM-40) were chosen since they were isolated from brain metastases of dierent patients (Zhang et al., 1991) and known to possess dierential metastatic propensities when injected in athymic nude mice (Gutman et al., 1994) . As shown in Figure 7 , an approximately 2 ± 3-fold increase of c-Yes activity was found in the brain-metastasis derived TXM-13 and TXM-18 cell lines upon stimulation by puri®ed, biologically active human NGF (4 nM) while no increase of c-Yes activity in the presence of NGF was observed in poorly metastatic TXM-40 cells treated with identical NGF concentrations. These ®ndings correlated well both with the dierential ability of these human melanoma cell lines to produce experimental metastases in nude mice and with presence of discriminatory levels of trk mRNA expression (Gutman et al., 1994) . Conversely, and similar to what was observed for the MeWo series, no appreciable stimulation of c-Src activity was detected upon incubation of TXM cells with NGF using the same experimental conditions as for c-Yes analysis (Figure 7) . Eect of human NGF on c-Src activity in human melanoma cells of dierent metastatic capabilities. Autoradiogram and scanning densitometric analysis comparing pp60 c-Src kinase activity in MeWo, 3 S 5 and brain-metastatic 70W cells following exposure with optimal concentrations of puri®ed NGF (2 nM). Total proteins from cells not exposed or exposed to human NGF were immunoprecipitated with antibodies speci®c for pp60 c-Src , kinase assays performed, and samples electrophoresed by SDS-polyacrylamide gels (refer to Materials and methods). A representative autoradiogram of independent experiments is shown Figure 5 Time-dependent human NGF stimulation of c-Yes in 70W cells. Cells were treated with an optimal concentration (2 nM) of puri®ed, biologically active human NGF, and harvested at times indicated in the ®gure. Two hundred and ®fty micrograms of total protein were immunoprecipitated with an antibody speci®c to c-Yes, and subjected to ICKA. Samples were fractionated by SDS-polyacrylamide gels then exposed to ®lm. Molecular size markers (in kilodaltons) were run in parallel and the position at 62 kDa is indicated. Autoradiograph signals were quanti®ed by scanning densitometry (refer to Materials and methods). Lane 1: 70W control, untreated. Lanes 2, 3, 4 and 5: 70W, stimulated with human NGF for 5 min, 1 h, 12 h, 24 h respectively 
Discussion
Malignant melanoma progresses through a series of clinically de®ned stages from benign proliferative lesions to highly aggressive metastatic disease capable of invasion and growth at distant organ sites. An unusual property of melanoma is that a primary metastatic target is the brain, and a frequent clinical end point of melanoma progression is the brain's colonization. Almost 40% of melanoma patients are treated for complications due to brain metastases, with nearly 90% of cases having CNS lesions at autopsy (Akslen et al., 1987) . Certainly, metastasis formation by malignant melanoma cells in the brain microenvironment is the result of a sequential multistep process where the successful metastatic clone must be able to respond to local concentrations of brain-speci®c growth factors (Wright and Delaney, 1989; and to synthesize and secrete a variety of ECMdegrading enzymes so as to solubilize those natural physical barriers that confront them (Nicolson et al., 1994a,b; Marchetti et al., 1996; Marchetti and Nicolson, 1997a,b) . We have previously demonstrated that NT are important factors aecting invasive processes of brain-metastatic melanoma cells: NGF and NT-3 but not BDNF and NT-4/5 stimulate invasive processes in these cells as well as the production of heparanase, an important ECM-degrading enzyme involved in tumor metastasis (Marchetti et al., , 1995 (Marchetti et al., , 1996 Nicolson et al., 1994a,b) . Correlative with selective NT-driven upregulation of invasion, the presence of aberrant levels of speci®c NT receptors in metastatic melanoma human samples has been reported (Marchetti et al., 1995) , with corresponding in vivo analyses using probes recently developed of NT/NTR biological system (Bothwell, 1990; Lamballe et al., 1991; Chao, 1992; Marchetti et al., 1995; Marchetti and Nicolson, 1997a,b) : only NT receptors corresponding to the neurotrophins NGF and NT-3 were found to be overexpressed in metastatic melanoma (Marchetti at al., , 1995 Herrmann et al., 1993) . Recently Loganzo et al. (1993) demonstrated that the non receptor tyrosine kinase (NRPTK) c-Yes is increased in expression and activity in malignant melanoma. The possible biological role(s) of this activation are currently unknown. The focus of the present work was to determine if neurotrophins that increase the metastatic potential of melanoma cells signal through c-Yes kinase. Human melanoma cells with diering metastatic capabilities were analysed and compared for c-Yes expression and its possible regulation by members of the NT family. We found that the expression and activity of c-Yes kinase activity is increased in melanoma cells with elevated brain-metastatic potential. Neurotrophins further increased Yes activity in cell lines metastatic to the brain, but not in cell lines of lower metastatic potential. The increase appears to be speci®c to c-Yes since the levels of c-Src protein and kinase activity are not aected by the prototypic NT, nerve growth factor (NGF). We also obtained indications that the c-Yes activity and protein levels were augmented in a number of clinical specimens from patients with brain-metastatic melanoma versus metastatic melanoma to sites other than brain and in primary lesions and normal scalp tissue obtained from the same patient (Marchetti et al., unpublished observations) .
These in vitro and clinical observations suggest that increased c-Yes NRPTK activity may play a role in the Figure 6 Scanning densitometric analysis of NT stimulation of c-Yes in human melanoma cells following ICKA analyses and autoradiography. Human melanoma cells of the MeWo series (MeWo, 3 S 5, 70W) were stimulated for 5 min with puri®ed preparations of biologically active human NT NGF and NT-3, at 2 nM ®nal concentration. ICKA were performed using a speci®c monoclonal antibody to c-Yes. Samples were then fractionated by SDS-polyacrylamide gels, exposed to Kodak X-AR ®lm and autoradiogram analysed Figure 7 Scanning densitometric analysis of NGF stimulation of c-Src and c-Yes in brain-metastasis-derived TXM melanoma cells following ICKA analyses and autoradiography. Human melanoma cells of the TXM series (TXM-13, TXM-18, and TXM-40) possessing dierential metastatic propensities (Gutman et al., 1994) were stimulated for 20 min at 378C with puri®ed preparations of biologically active human NGF at 4 nM ®nal concentration. ICKA were performed using a speci®c monoclonal antibody to c-Yes. Samples were then fractionated by SDSpolyacrylamide gels, exposed to Kodak X-AR ®lm and autoradiogram analysed c-Yes upregulation by neurotrophins in human brain-metastatic melanoma D Marchetti et al malignant progression of melanoma, speci®cally to the brain-metastatic phenotype. The molecular basis for the elevated expression of c-Yes and regulation by the NTs is not yet clear. c-Yes expression has been found to be augmented in other cell types (e.g., various epithelial cells such as lung, kidney, and intestine) and in neural tissues (Sudol, 1988; Sudol et al., 1989; Zhao et al., 1990) . Our current work links changes in pp62 c-Yes activity in brain metastases with in vitro regulation of pp62 c-Yes activity by NT. We showed that brain-metastatic melanoma metastases do have increased pp62
c-Yes activity and that such an increase is minimal for melanoma metastatic to sites other than brain or refractory to any metastasis formation. These results not only corroborate the concept that speci®c interactions of parenchyma and tumor cells at the site of metastatic implantation may vary from site to site (Nicolson et al., 1986) but also support the idea that local factors like the NT may aect the pp62 c-Yes tyrosine kinase activity within a speci®c microenvironment such the brain. Interestingly, c-Yes is expressed at elevated levels in neural tissues (Sudol, 1988) ; the expression pattern for c-Yes protein in areas of adult rat brain correlate with regions where NT synthesis and expression has been demonstrated (Whittemore and Seiger, 1987; Lindsay et al., 1994) . Some of these brain areas are exquisite targets of colonization by metastatic melanoma cells capable of forming brain metastases. Since there are no obvious structural or localization defects in c-Yes in melanoma cells (Loganzo et al., 1993) , it is possible that simple overexpression of c-Yes could provide a threshold phenomenon in which the normal function of this protein is perturbed (Jacobovitz et al., 1984) . While cSrc is believed to be involved in normal melanocyte growth, dierentiation, or function (O'Connor et al., 1992) , the function of c-Yes in melanocytic cells is unknown. However, it has been hypothesized that NRPTKs like c-Yes may transduce and/or amplify external signals by accessing proteins incapable of being phosphorylated by receptor-type PTKs (Grandori et al., 1991) . Evidence supporting this possibility is derived from the observations that c-Yes is physically associated with the receptor of platelet-derived growth factor (Kypta et al., 1997) . Similarly, an association occurring between Her-2/neu and c-Src has been reported (Guy et al., 1992) . It is therefore reasonable to assume a possible constitutive association between cYes and NTR (p75 NTR , TrkC) that are overexpressed in brain-metastatic melanoma with possible dimers formation on the cell surface. Analogously, increases in c-Yes NRPTK in melanoma cells may alter the normal spectrum of protein interactions, i.e., by accessing and phosphorylating novel substrates, thus participating in the transformation process (Grandori et al., 1991) . The consistent elevation of pp62 c-Yes activity and level in brain-metastatic melanoma and its speci®c regulation by select NT NGF and NT-3 provide clues to the signaling pathways for Yes enzymes in the central nervous system. Additionally, our results suggest possible diagnostic and therapeutic applications for this oncogene product. For instance, the identi®cation and characterization of metastasisspeci®c tyrosine kinase substrates could reveal important diagnostic molecular markers for tumor progression. Of importance therefore is the development of speci®c tyrosine kinase inhibitors for use in molecular antineoplastic therapy applicable, as in our case, to brain-invasive processes by metastatic melanoma cells. The results presented here should provide important insights as to the role of NRPTK activation in melanomas and the potential involvement of NRPTK in the development of brain metastases. They also argue for further studies into potential roles for altered c-Yes in the pathogenesis of melanoma.
Materials and methods

Cells lines, tissue culture and NT treatment
The human MeWo melanoma cells and its WGA-resistant mutants 3 S 5 and 70W (Ishikawa et al., 1988a,b) were maintained as monolayer cultures in a 1:1 (v/v) mixture of DMEM/F12 medium (Gibco, Grand Island, New York) supplemented with 5% fetal bovine serum (FBS; Gibco) at 378C in a humidi®ed atmosphere (5% CO 2 795% air). Cells were removed from the substratum by trypsin-EDTA treatment and subcultured every 3 ± 4 days. Only subconuent cells of less than ®ve passages from the original frozen stock were used. TXM lines were maintained as monolayer cultures as originally described (Zhang et al., 1991; Gutman et al., 1994) . NT-exposed cultures were fed and maintained in medium without serum and were treated with various concentrations of puri®ed and biologically active human NT at cell densities of 2 ± 8610 5 /35 mm culture dish for up to 72 h. NT bioassays were performed to show their biological activity (Greene and Tischler, 1976) . Twenty-four-hours before NT treatment, medium was changed to medium without serum. Following treatment, cells were collected by scraping the surface of the tissue-culture dish, washed, and analysed for c-Yes content and activity as described below. Only Mycoplasmafree cell lines were used in this study.
Cell lysate preparation
Culture media were removed from cell monolayers, and cells were washed with cold PBS. Cells were lysed in 16RIPA buer (1% Triton X-100, 150 mM NaCl, 5 mM EDTA, 1% aprotinin, 5 mM PMSF, 10 mg/ml leupeptin, and 20 mM Na-phosphate, pH 7.4) for 1 ± 2 min. Cells were subsequently scraped away using a`rubber policeman' and transferred to a homogenizer on ice. Homogenization was performed 50 ± 60 times. Cell lysates were then transferred to Corex tubes and centrifuged at 10 000 r.p.m. at 48C for 10 min. Protein concentration was then performed as described below. Immunoprecipitation with MAb 327 anti-src (Oncogene Science Inc., Uniondale, NY) or with antibody against c-Yes (Wako Inc., Richmond, VA) followed.
Immune Complex Kinase Assay (ICKA)
Aliquots of lysates containing 250 mg of cellular protein were incubated with an excess (600 ng) of antibody speci®c for c-Src or c-Yes for 1 h on ice. A secondary antibody was incubated with lysates for 1 h on ice. Samples were then incubated with 50 ml of 10% (v/v) formalin-®xed Staphylococcus aureus (Pansorbin; Calbiochem., La Jolla, CA), incubated on ice for 30 min, and later microfuged for 2 min. Pellets were washed three times with 1 ml ICKA buer (0.1% Triton X-100, 150 mM NaCl, 10 mM Naphosphate, pH 7.4), after which pellets were drained and kinase reaction buer (20 mM HEPES/100 mm Na-orthovanadate buer containing 8 mM MgCl 2 ) was added with [ 32 P]ATP (10 mCi/sample). Incubation for 10 min at room c-Yes upregulation by neurotrophins in human brain-metastatic melanoma D Marchetti et al temperature (258C) followed. Subsequently, pellets were washed three times with 1 ml of 16RIPA buer and drained. The reaction was terminated in sample buer consisting of 125 mM Tris, pH 6.8, 2% SDS, 5% bmercaptoethanol, 1 mM EDTA, 10% glycerol, and 0.02% bromophenol blue. Proteins were resolved on 8% SDS ± PAGE, and radiolabeled proteins were detected by autoradiography with Kodak X-omatic AR ®lm (Eastman Kodak Co., Rochester, NY) with an intensifying screen at 7808C for 1 ± 4 days. Enolase assays were also performed to eliminate the possibility that the speci®c activity of Src/ Yes did not change.
Immunoblot analysis of pp62 c-Yes
Lysates containing 200 mg of cellular protein were resolved by 8% SDS ± PAGE and transferred to nitrocellulose (0.1 mm pore size) (Schleicher & Schuell, Inc., Keene, NY) at 100 V for 3 h at 48C in transfer buer (200 mM glycine, 25 mM Tris, 20% methanol). After the transfer was complete, the nitrocellulose ®lter was incubated in preadsorption buer [3% BSA and 5% low fat (2% or less) milk in TTBS (50 mM Tris, 0.1 M NaCl, 0.2% Tween 20, pH 7.15)] at 378C for 16 h with shaking. The ®lters were incubated with 600 ng of c-Yes antibody per lane at 48C for 3 h with shaking. Filters were then washed ®ve times for 15 min each time in TTBS, then incubated with 10 6 c.p.m. of 125 I-labeled rabbit antimouse IgG per lane for 2 h at 258C. Following ®ve washes in TTBS, the nitrocellulose was dried and exposed to Kodak X-omatic AR ®lm with an intensifying screen at 7808C.
Quantitation and analysis of data
Relative phosphorylation of pp60 c-Src and pp62 c-Yes in the ICKA buer and pp62 c-Yes levels in the immunoblots were determined by measuring the intensities of the appropriate bands in autoradiographs by densitometric scanning. Densitometric analyses were performed using a Beckman DU-10 spectrophotometer.
